Rennie Extra chewable tablets

국가: 영국

언어: 영어

출처: MHRA (Medicines & Healthcare Products Regulatory Agency)

지금 구매하세요

Download 환자 정보 전단 (PIL)
01-11-2018
Download 제품 특성 요약 (SPC)
13-12-2019

유효 성분:

Calcium carbonate; Alginic acid; Magnesium carbonate heavy

제공처:

Bayer Plc

ATC 코드:

A02AX

INN (국제 이름):

Calcium carbonate; Alginic acid; Magnesium carbonate heavy

복용량:

625mg ; 150mg ; 73.5mg

약제 형태:

Chewable tablet

관리 경로:

Oral

수업:

No Controlled Drug Status

처방전 유형:

Never Valid To Prescribe As A VMP

제품 요약:

BNF: 01010201; GTIN: 5010605300103 5010605300134

환자 정보 전단

                                Bayer Ref No:
Reference No:
Brand:
Range:
Product:
Pack Type:
Pack Size:
Action:
Date:
Country:
Finished Goods Code:
Synaps Request Code:
Component Code:
CAD Ref No:
Printer:
Packaging Site:
Substrate:
Barcode 1 Type:
Barcode 1 Mag:
Barcode 2 Type:
Barcode 2 Mag:
Pharmacode No/NE:
PIL 135 x 197 (SB712B)
Rennie
Chew Tablets
Extra
Leaflet
UK
Please note that any low resolution paper Canon colour
copies associated with this job should be referred to for
content, layout and colour separation only.
UNDER NO CIRCUMSTANCES SHOULD THIS
ARTWORK BE ALTERED WITHOUT PRIOR
PERMISSION FROM
.
STUDIO USE ONLY
v1.0
Sm•Art check results:
Cutter
Guides
Technical & Non Printing Items
BAYER ARTWORK PANEL
12/24 Pack
Packaging Site Approval:
ARTWORK
APPROVAL PANEL
Name:
Date:
Action:
Country Approval:
Name:
Date:
Action:
BAY352321
Main Text (body copy):
Height (based on lower case x):
8 pt
1.4 mm
FONT SIZE PANEL
22/02/19
00000000
B
TR1482273
G=1; O=2; R=0; - LG - 22/02/19 12:53:13
Code 128
44%
N/A
N/A
N/A
White Paper
1
LTH
Process Black
Colours
Calcium carbonate, Magnesium carbonate, Alginic acid
Chewable tablets
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
Always take this medicine exactly as described in this leaflet or as
your doctor or pharmacist has told you.
-
Keep this leaflet. You may need to read it again.
-
Ask your pharmacist if you need more information or advice.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not listed in this leaflet. See
section 4.
-
You must contact a doctor
if you do not feel better or if you feel worse after 14 days.
WHAT IS IN THIS LEAFLET
1.
What Rennie Extra Tablets are and what they are used for
2.
What you need to know before you take Rennie Extra Tablets
3.
How to take Rennie Extra Tablets
4.
Possible side effects
5.
How to store Rennie Extra Tablets
6.
Contents of the pack and other information
1.
WHAT RENNIE EXTRA TABLETS ARE AND WHAT THEY ARE USED FOR
Re
                                
                                전체 문서 읽기
                                
                            

제품 특성 요약

                                SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Rennie Extra Tablets
Rennie Dual Action Chewable Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each chewable tablet contains:
Alginic acid 150mg, calcium carbonate 625mg and heavy magnesium
carbonate 73.50mg.
Excipients: each chewable tablet contains 14 mg sodium as well as
sucrose
(230mg) and glucose (555.22 mg).
For a full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Chewable tablet (tablet)
Off white, speckled circular tablet, flat on both sides with a
bevelled edge.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Symptomatic treatment of complaints resulting from gastro-oesophageal
reflux
and hyperacidity, such as regurgitation and heartburn.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
The usual dose is 2 tablets to be chewed. It should preferably be
taken one
hour after meals and before going to bed. An additional dose can also
be taken
in between in the case of heartburn. The maximum dose of 8 grams
calcium
carbonate (corresponding to 12 tablets) per day should not be exceeded
and
should not be taken continuously for longer than 2 weeks. Only for use
by
adults and children over 12 years of age.
As with all antacids, if symptoms persist despite 14 days of
continuous
therapy, diagnostic measures are strongly recommended in order to rule
out a
more serious disease.
For Special warning and precautions for use please also see section
4.4.
4.3
CONTRAINDICATIONS

Severe renal insufficiency

hypercalcaemia and/or conditions resulting in hypercalcaemia

pre-existing hypophosphataemia

nephrolithiasis due to calculi containing calcium deposits

hypersensitivity to the active substances or to any of the excipients.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Prolonged use should be avoided.
If the symptoms persist or only partly disappear, further medical
advice should
be sought.
As with other antacids, Rennie Extra tablets may mask a malignancy in
the
stomach.
Rennie Extra tablets should not be used in the following cases:


                                
                                전체 문서 읽기